Biodefense Diplomacy Enhancement Act
- Bill Number
- S. 4491
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 2
- Status
- Introduced
- Latest Action
- 2026-05-12: Read twice and referred to the Committee on Foreign Relations.
- Last Updated
- 2026-05-19T00:53:28Z
AI-Generated Summary
Purpose
The purpose of this legislation is to strengthen U.S. diplomatic efforts to improve cooperation with allies and partners on matters related to biodefense, biosecurity, and biotechnology. It focuses on advancing foreign policy goals to address biological threats through better planning, standards, and international coordination.
Key Provisions
- The Secretary of State must lead efforts to enhance cooperation, with possible delegation to the Under Secretary for Arms Control and International Security, while coordinating with the Under Secretary for Political Affairs and the U.S. representative to NATO.
- Within NATO, the bill calls for prioritizing policy development on biodefense topics such as biotechnology, biosurveillance, and countermeasures; reviewing and updating NATO's existing Chemical, Biological, Radiological, and Nuclear Defence Policy; improving allied capabilities for detecting and responding to biological attacks; and promoting high safety standards in biological research.
- With other U.S. allies and partners, including major non-NATO allies, the bill directs exploration of cooperation areas, coordination on export controls for biotechnology items that could pose security risks if misused for military purposes, promotion of safety standards, and support for enforcing the Biological Weapons Convention (the international treaty prohibiting the development and stockpiling of biological weapons).
- The bill requires development of two strategies: a "NATO Biodefense Strategy" assessing current cooperation and gaps, and an "International Biotechnology, Biosecurity, and Biodefense Cooperation Strategy" outlining potential agreements, export control coordination beyond existing regimes like the Wassenaar Arrangement and Australia Group, and use of related programs and funds.
- A report containing these strategies must be submitted to congressional committees within 270 days, and briefings must be provided within 90 days on related developments.
- The strategies are limited to threats from biological agents and toxins as defined in federal law (18 U.S.C. § 178).
Significant Changes to Existing Law
This legislation introduces new directives for the Department of State without directly amending prior statutes. It establishes formal requirements for strategy development, NATO-specific policy advocacy, and expanded diplomatic reporting on biodefense topics, building on existing frameworks like the Biological Weapons Convention and export control regimes.
Potential Impacts
- Government Agencies: The Department of State would take on additional coordination and strategy roles, potentially requiring more resources and interagency collaboration for diplomacy and biosecurity efforts.
- Citizens: Improved international cooperation could indirectly strengthen protections against biological incidents by enhancing detection, response, and prevention capabilities.
- International Relations: The bill may foster closer ties with NATO members and other partners through shared policies and standards, while encouraging global adherence to safety and nonproliferation norms in biotechnology.
Main Stakeholders
- The U.S. Department of State and its relevant undersecretaries.
- NATO and its member states.
- Other U.S. allies and partners, including major non-NATO allies.
- Congressional committees on foreign relations and foreign affairs.
- U.S. government agencies involved in biodefense and security matters.
Notable Legal, Constitutional, or Political Implications
- Authority is delegated to specific State Department officials, aligning with executive branch foreign policy powers.
- The bill references and supports enforcement of the Biological Weapons Convention without creating new legal obligations under it.
- It emphasizes export controls on dual-use biotechnology items (those usable for both civilian and military purposes) to mitigate national security risks.
- Scope is restricted to biological threats, avoiding broader applications, with no apparent constitutional conflicts as the focus remains on diplomacy and international cooperation.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (1)
Recent Actions
- 2026-05-12: Read twice and referred to the Committee on Foreign Relations.
- 2026-05-12: Introduced in Senate
Bill Versions
- Biodefense Diplomacy Enhancement Act — issued 2026-05-12 — PDF (9 pages)